The ARV Therapies and Therapeutic Strategies program is a comprehensive, independent review of the 16th European AIDS Conference (EACS 2017). This program consists of five components: (1) EACS 2017 Expert Review: a 1.5 hour Internet symposium that features an overview and discussion of key presentations and posters, selected by the expert faculty discussants; (2) European Perspective on EACS 2017**: a 1.5 hour Case-based Internet symposium featuring Europe based expert faculty reviewing and discussing key presentations with a focus on clinical management and treatment in the EU; (3) Comprehensive Expert Review and Discussion of Key Presentations: an on-line, in-depth review of 8 of the key poster/presentations reviewed in the Internet symposium (4) Rapid-Fire Review of EACS 2017: a podcast that provides a brief, audio summary of the most essential data presented at the conference; and (5) From Conference to Clinic: Reviewing and Applying Data From EACS 2017: case-based live meetings during which the key data are reviewed, discussed and applied to patient care.
The Comprehensive Expert Review and Discussion of Key Presentations part of the program will feature HIV experts reviewing and discussing the most important studies on HIV therapy presented at EACS 2017. This review and discussion will provide a comprehensive overview of each of the posters and presentations selected. In addition, the faculty will provide unique insights into how knowledgeable experts review and analyze data from EACS 2017 and an in-depth understanding of the scientific quality and clinical relevance of the posters and presentations reviewed.
All online components of the program will be accessible at www.viraled.com.
This program is produced by the Postgraduate Institute for Medicine and ViralEd, Inc. It is not a session created by or presented at EACS 2017 and it is not sanctioned by the organizers of EACS 2017.
** The European Perspective on EACS 2017 component is jointly provided by the Annenberg Center for Health Sciences at Eisenhower and ViralEd, Inc. in collaboration with Postgraduate Institute for Medicine and supported by an independent educational grant from ViiV Healthcare.
This activity has been designed to meet the educational needs of physicians, physician assistants, advanced practice nurses and other health care professionals involved in the care of patients with HIV infection.
After completing this activity, the participant should be better able to:
Use data reported at EACS 2017 for counseling, testing and antiretroviral treatment to prevent HIV infection, especially in underserved communities
Use in a clinical setting findings from key studies on HIV/AIDS diagnosis, management, and treatment presented at EACS 2017
Employ strategies based on studies and data presented at EACS 2017 for helping HIV-positive patients in medically underserved communities link to and stay in appropriate and effective HIV care
Release Date: November 13, 2017
Expiration Date: November 13, 2018
Estimated time to complete each Poster/Presentation: 15-30 minutes
Media: Internet
|
José Arribas, MD |
Graeme Moyle, MD, MB, BS Associate Director of HIV Research Chelsea & Westminster Hospital London, United Kingdom |
|
Marta Boffito, MD, PhD St. Stephen's AIDS Trust and Imperial College Chelsea & Westminster Hospital London, United Kingdom |
Jürgen Rockstroh, MD Professor of Medicine Department of Medicine I University Hospital Bonn, Germany |
|
Ian Frank, MD Professor of Medicine Director, Clinical Therapeutics Program Penn Center for AIDS Research Perelman School of Medicine at the University of Pennsylvania Philadelphia, Pennsylvania |
Mike Youle, MD Director of HIV Clinical Research Royal Free Hospital London, United Kingdom
|
|
Jean-Michel Molina, MD, PhD Head, Infectious Diseases Department Hospital Saint-Louis Pairs, France |
|
|
Franco Maggiolo, MD
Head, Infectious Diseases Department
|
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and ViralEd, Inc. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. There will be 8 posters and presentations available for a total of 2.00 possible credit hours.
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Jose Arribas, MD
Ian Frank, MD
Jean-Michel Molina, MD, PhD
Juergen Rockstroh, MD
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of these CME activities:
The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN and Jan Shultz, MSN, RN, CHCP have nothing to disclose.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Postgraduate Institute for Medicine, ViralEd, Inc., and Gilead Sciences Medical Affairs. do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Postgraduate Institute for Medicine, ViralEd, Inc., and Gilead Sciences Medical Affairs. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired
information to enhance patient outcomes and their own professional
development. The information presented in this activity is not meant to
serve as a guideline for patient management. Any procedures,
medications, or other courses of diagnosis or treatment discussed or
suggested in this activity should not be used by clinicians without
evaluation of their patient’s conditions and possible contraindications
on dangers in use, review of any applicable manufacturer’s product
information, and comparison with recommendations of other
authorities.
This program is produced by the Postgraduate Institute for Medicine and ViralEd, Inc. It is not a session created by or presented at EACS 2017 and it is not sanctioned by the organizers of EACS 2017.
This activity is supported by an independent educational grant from Gilead Sciences Medical Affairs.
